Elizabeth Lanphier Headshot

Elizabeth Lanphier

Assistant Professor of Pediatrics, University of Cincinnati
Chapter Member: Central Ohio SSN
Areas of Expertise:

About Elizabeth

Lanphier is a moral philosopher and clinical ethicists specializing in healthcare ethics. Her research is broadly focused on healthcare justice and access, especially topics in reproductive ethics, pediatric ethics, and healthcare provision for incarcerated populations. Lanphier also has expertise in trauma informed care and ethics, and narrative practices in healthcare. Lanphier is an elected board member of the Bioethics Network of Ohio and a steering committee member for the collective impact organization Joining Forces for Children, which brings together partners in the Cincinnati region to help kids, families, and communities to build resilience and overcome adversity.

In the News

Opinion: " Off-Label’ Use Is Common in Medicine – A Bioethicist and Legal Philosopher Explain Why the COVID-19 Vaccines Are Different," Elizabeth Lanphier, Ethics + Religion, The Conversation, November 17, 2021.
Opinion: "Vaccine Guilt Is Good – As Long It Doesn’t Stop You From Getting a Shot," Elizabeth Lanphier, The Conversation, April 7, 2021.
Opinion: "Ohio’s Vaccination Plan Used To Include Incarcerated People. Now It Doesn’t," Elizabeth Lanphier, Opinion, Cincinnati.com The Enquirerer, March 25, 2021.
Opinion: "Prisoners, at Great Risk, Should Get Vaccine Early the Columbus Dispatch," Elizabeth Lanphier, Columns|Opinion, The Columbus Dispatch, December 21, 2020.
Opinion: "Where No Lives Matter," Elizabeth Lanphier, The Philosophical Salon, August 3, 2020.
Opinion: "Bill Lee’s Pro-Life Message Is Contradicted by Death Penalty Stance," Elizabeth Lanphier, Opinion, Tennessean, July 31, 2020.

Publications

"Over-the-Counter Oral Contraceptives in the Context of State Abortion Bans" (with Hunter Jackson Smith and Jake Earl). Journal of General Internal Medicine (2023).

Discusses the FDA's approval of Opill, a progestin-only norgestrel tablet, for over-the-counter (OTC) access. Emphasizes that while OTC oral contraceptives can enhance accessibility and decrease unplanned pregnancies, they are not a complete solution to post-Dobbs abortion restrictions. Argues that clinicians must maximize the benefits of OTC contraceptives while continuing to advocate for safe and accessible abortion care.